Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

Author(s):
Hovingh, G.K.; Kastelein, J.J.P.; Deventer, S.J.H. van; Round, P.; Ford, J.; Saleheen, D.; Rader, D.J.; Brewer, H.B.; Barter, P.J.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-08-01
Language
English
Is part of
Lancet (2015), Vol. 386, no. 9992, p. 452-460
hdl
1887/117246
doi
10.1016/S0140-6736(15)60158-1